1-2 of 2
Jutte Van der Werff Ten Bosch, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Deciphering Molecular Heterogeneity in Pediatric AML Using a Cancer Vs Normal Transcriptomic Approach

Barbara Depreter, PhD PharmD, Mattias Hofmans, MD, Eva Terras, Anne Uyttebroeck, MD, An Van Damme, MD, Alina Ferster, MD, Jutte Van der Werff Ten Bosch, MD, Marie-Françoise Dresse, MD PhD, Karl Vandepoele, PhD, Barbara De Moerloose, MD PhD, Jan Philippé, MD PhD, Tim Lammens, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1457.
https://doi.org/10.1182/blood-2019-125538
Published: 2019
Journal Articles

Risk-Group Stratified and Minimal Residual Disease (MRD)-Guided Treatment with Extended ATRA and Reduced-Anthracycline Chemotherapy in Childhood Acute Promyelocytic Leukemia (APL): Results from ICC APL Study 01 (NCT01226303; EudraCT 2008-002311-40)

Anna Maria Testi, MD, Andrea Pession, MD, David Grimwade, PhD FRCPath, Daniela Diverio, PhD, Christine Ragu, PhD, Sarah Elitzur, MD, Alcira Fynn, MD, Henrik Hasle, MD PhD, Jutte Van der Werff ten Bosch, MD PhD, Owen Smith, MD, Brenda Gibson, MD, Franco Locatelli, MD PhD, Gertjan J.L. Kaspers, MD PhD
Journal: Blood
Blood (2015) 126 (23): 563.
https://doi.org/10.1182/blood.V126.23.563.563
Published: 2015